Ozanimod for the treatment of relapsing forms of multiple sclerosis
Volume: 11, Issue: 3, Pages: 207 - 220
Published: Jun 1, 2021
Abstract
Multiple sclerosis (MS) is an inflammatory disease that causes chronic neurological disability in young adults. Modulation of sphingosine 1-phosphate (S1P) receptors, a group of receptors that, among other things, regulate egression of lymphocytes from lymph nodes, has proven to be effective in treating relapsing MS. Fingolimod, the first oral S1P receptor modulator, has demonstrated potent efficacy and tolerability, but can cause undesirable...
Paper Details
Title
Ozanimod for the treatment of relapsing forms of multiple sclerosis
Published Date
Jun 1, 2021
Volume
11
Issue
3
Pages
207 - 220
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History